Physician

Mark G Delworth, MD

According to 2025 Medicare claims, Mark Delworth, MD (NPI: 1275579856) practices urology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is TRI STATE UROLOGIC SERVICES PSC INC (NPI: 1568404846; TIN: 611257391) and primary practice location at 45212-1979.

Delworth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,039 traditional Medicare patients, billed 19,771 HCPCS/CPT codes, and received $710,567 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,387 prescription claims across 676 beneficiaries totaling $7,774,468 in drug costs, led by Xtandi (Enzalutamide). DME data shows 749 claims. Open Payments data shows 111 records totaling $8,875. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,373,078 to $7,774,468. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,307 and ending at $877.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	828	13,485	$453,819
2016	940	20,554	$486,724
2017	935	21,187	$494,671
2018	960	20,768	$471,779
2019	979	19,427	$489,398
2020	997	19,881	$511,409
2021	1,007	19,227	$505,568
2022	935	18,445	$505,329
2023	1,007	20,313	$648,345
2024	1,039	19,771	$710,567

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	450	2,001	$1,373,078
2016	451	2,005	$1,645,350
2017	439	1,808	$2,138,777
2018	408	1,858	$3,015,630
2019	487	2,116	$3,754,740
2020	536	2,594	$5,623,239
2021	561	2,844	$6,614,591
2022	563	2,768	$6,926,149
2023	615	2,845	$6,723,583
2024	676	3,387	$7,774,468

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	117	466	$46,523
2016	134	492	$51,422
2017	165	538	$62,796
2018	182	626	$64,761
2019	200	756	$87,970
2020	218	842	$88,544
2021	214	847	$82,874
2022	221	893	$89,904
2023	180	700	$88,794
2024	181	749	$91,999

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	700	1,110	$89
84153	Psa (prostate specific antigen) measurement, total	469	853	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	659	980	$11
36415	Insertion of needle into vein for collection of blood sample	498	926	$9
81002	Urinalysis, manual test	601	861	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	342	10,512	$4,531,646
Erleada	Apalutamide	77	2,700	$1,218,480
Nubeqa	Darolutamide	41	1,230	$552,503
Orgovyx	Relugolix	157	4,676	$419,080
Talzenna	Talazoparib Tosylate	15	450	$265,940

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	29	102	$15,156
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	20	60	$13,921
A4430	Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each	N	15	75	$13,431
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	23	$13,272
A4432	Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each	N	27	84	$12,113

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	111	$8,875	Janssen Scientific Affairs, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark G. Delworth, MD?

Tedicare shows public-source Medicare data for Mark G. Delworth, MD (NPI 1275579856), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark G. Delworth, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark G. Delworth, MD?

Mark G. Delworth, MD is linked to TRI STATE UROLOGIC SERVICES PSC INC (billing NPI 1568404846) in the available physician profile data.

Does Mark G. Delworth, MD have Open Payments data?

Mark G. Delworth, MD has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.